Pharmaceutical ResearchNews - Page 1

Government invests more than £74m in UK life sciences for cutting-edge innovations

Science
Funding for UK life sciences could manufacture medicines and transform spent nuclear fuel into the next generation of cancer therapies.

How artificial intelligence will supercharge transformative change for ALS drug discovery

Health
Learn about the Longitude Prize on ALS, the personal story behind its creation, and how AI can help to transform treatment and care for ALS.

BioNxt Solutions fast-tracks US patent for drug delivery platform

Partner News
BioNxt marks two key milestones in the expansion of its proprietary drug delivery platform targeting neurological autoimmune disorders.

Positive results for BioNxt’s cladribine sublingual thin-film

Partner News
BioNxt Solutions has announced successful formulation of a sublingual thin-film prototype for its lead clinical stage candidate, BNT23001.

Optogenetic screening creates new opportunities for age-related diseases

Health
Discover how a new platform combines optogenetics, chemistry, and AI to discover small-molecule therapeutics for age-related diseases.

BioNxt’s sublingual cladribine solution ready for next phase of development

Partner News
BioNxt Solutions Inc. has announced the receipt of its thin-film formulation of sublingual cladribine for the treatment of multiple sclerosis.

BioNxt launches study for semaglutide oral thin film as alternative to injection/tablets

Partner News
BioNxt Solutions announces the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under the brand names Ozempic®, Rybelsus®, and Wegovy®.

Kite presents CAR T-cell therapy portfolio at ICML 2025

Partner News
T-cell therapy data includes real-world outcomes from the largest cohort of patients treated for B-cell lymphoma.

BioNxt Solutions expands research and development with Munich laboratory

Partner News
BioNxt Solutions' integration with Gen-Plus provides advanced research and development capabilities with a major biotech hub.

NHS rolls out 5-minute nivolumab jab for 15 cancers

Health
Nivolumab, an injectable form of immunotherapy, means patients can receive their fortnightly or monthly treatment in 5 minutes.

EU proposes Critical Medicines Act to secure pharma supply chains

Health
Discover how the EU's Critical Medicines Act aims to strengthen pharmaceutical security, reduce shortages, and boost local manufacturing.

No current bird flu vaccine meets full criteria, experts say

Environment
As the UK enters the fourth season of regular bird flu outbreaks, farmers are calling for measures that extend beyond ‘robust biosecurity’.

TRIUMF and actinium-225 – the ‘world’s rarest drug’

Science
By developing isotopes like actinium-225, the research and development teams at TRIUMF have the potential to revolutionise cancer care.

Strategising vaccine supply chains in developing countries

Health
Learn more about the challenges and opportunities in optimising vaccine supply chains in developing countries such as Sierra Leone and Niger.

Over a third of pregnant women offered new RSV vaccine in first month

Health
The RSV vaccines gives vital protection to newborns from the first day of life against what can be a severe and life-threatening illness.

How vaccines can improve cardiovascular health in the EU

Health
The EU needs additional measures to address existing gaps and enhance the effectiveness of initiatives to improve cardiovascular health.

MedSafetyWeek 2025: Preventing medicine side effects

Health
MedSafetyWeek is part of efforts to raise awareness about the importance of reporting medicine side effects to regulatory authorities.

UK welcomes £50m boost for medicines manufacturing

Health
The £50m deal with Accord will build a state-of-the-art medicines manufacturing facility incorporating the latest automation technology.

How explainable AI could speed up drug discovery

Health
Explainable AI, a subset of standard AI technology, could help design new molecules for medications. Read more here.

Scientists discover superbug’s rapid path to vancomycin resistance

Health
The hospital superbug C.diff rapidly evolves vancomycin resistance - the frontline drug used for treatment in the UK.
123...5Page 1 of 5

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd

Innovation News Network brings you the latest research and innovation news from the fields of science, environment, energy, critical raw materials, technology, and electric vehicles.

Science

Environment

Energy

Transport

Disclaimer: This website is an independent portal and is not responsible for the content of external sites.
Please Note: Phone calls may be recorded for training and monitoring purposes.
© Pan European Networks Ltd